In utero hematopoietic stem cell transplantation: A status report

JAMA

Volumn 278, Issue 11, 1997, Pages 932-937

  Flake, Alan W ^a,c   Zanjani, Esmail D ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; CHEDIAK HIGASHI SYNDROME; COMBINED IMMUNODEFICIENCY; FETUS CELL; FETUS SURGERY; GENE THERAPY; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; HURLER SYNDROME; IMMUNE DEFICIENCY; MEDICAL ETHICS; METACHROMATIC LEUKODYSTROPHY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STEM CELL TRANSPLANTATION;

EID: 0030728405     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.11.932     Document Type: Article

References (49)

1. Billingham R, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature. 1953;172: 603-606.
2. Owen RD. Immunogenetic consequences of vascular anastomoses between bovine cattle twins. Science. 1945;102:400-401.
3. Picus J, Aldrich W, Letvin N. A naturally occurring bone-marrow chimeric primate. Transplantation. 1986;39:297-303.
4. van Dijk B, Bommsma D, de Man A. Blood group chimerism in human multiple births is not rare. Am J Med Genet. 1996;61:264-268.
5. Fleischman R, Mintz B. Prevention of genetic anemias in mice by microinjection of normal hematopoietic cells into the fetal placenta. Proc Natl Acad Sci U S A. 1979;76:5736-5740.
6. Flake AW, Harrison MR, Adzick NS, Zanjani ED. Transplantation of fetal hematopoietic stem cells in utero. Science. 1986;233:776-778.
7. Harrison MR, Slotnick RN, Crombleholme TM, Golbus MS, Tarantal AF, Zanjani ED. In-utero transplantation of fetal liver haemopoietic stem cells in monkeys. Lancet. 1989;2:1425-1427.
8. Zanjani ED, Pallavicini MG, Ascensao JL, et al. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest. 1992;89: 1178-1188.
9. Zanjani ED, Flake AW, Rice H, Hedrick M, Tavassoli M. Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J Clin Invest. 1994;93:1051-1055.
10. Linch D, Rodeck C, Nicolaldes K, et al. Attempted bone marrow transplantation in a 17-week fetus. Lancet. 1986;1:1382.
11. Touraine JL, Raudrant D, Royo C, et al. The in-utero transplantation of stem cells in bare lymphocyte syndrome. Lancet. 1989;1:1382.
12. Touraine JL. Stem cell transplantation in primary immunodeficiency, with special reference to the first prenatal, in utero, transplants. Allergol Immunopathol (Madr). 1991;19:49-51.
13. Touraine JL, Raudrant D, Rebaud, A, et al. In utero transplantation of stem cells in humans. Bone Marrow Transplant. 1992;1:121-126.
14. Slavin S, Naparstek E, Ziegler M, et al. Clinical application of intrauterine bone marrow transplantation for treatment of genetic disease: feasibility studies. Bone Marrow Transplant. 1992;1:189-190.
15. Diukman R, Golbus MS. In utero stem cell therapy. J Reprod Med. 1992;37:515-520.
16. Thilaganthan B, Nicolaides K. Intrauterine bone-marrow transplantation at 12 weeks' gestation. Lancet. 1993;342:243.
17. Cowan M, Golbus MS. In utero hematopoietic stem cell transplants for inherited disease. Am J Pediatr Hematol Oncol. 1994;16:35-42.
18. Westgren M, Ringden O, Sturla E-N, et al. Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies. Transplantation. 1996;61:1176-1179.
19. Blakemore K, Bambach H, Moser H, et al. Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy. Am J Obstet Gynecol 1996;174:312. Abstract.
20. Flake AW, Roncarolo M-G, Puck JM, et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med. 1996;335:1806-1810.
21. Wengler G, Lanfranchi A, Frusca T, et al. Inutero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDX1). Lancet. 1996;348:1484-1487.
22. Haynes BF, Martin ME, Kay HH, Kurtzberg J. Early events in human T-cell ontogeny. J Exp Med. 1988;168:1061-1080.
23. Lobach DF, Hensley LL, Ho W, Haynes BF. Human T-cell antigen expression during early stages of fetal thymic maturation. J Immunol. 1985; 135:1752-1759.
24. Silverstein A, Prendergast R, Kraner K. Fetal response to antigenic stimulus, IV: rejection of skin homografts by the fetal lamb. J Exp Med. 1964;119: 955-964.
25. Buckley RH, Schiff SE, Schiff RI, et al. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency. Semin Hematol. 1993;30:92-104.
26. Rice HE, Hedrick MH, Flake AW, Donegan E, Harrison MR. Bacterial and fungal contamination of human fetal liver collected trans vaginally for hematopoietic stem cell transplantation. Fetal Diagn Ther. 1993;8:74-78.
27. Cefalo RC, Berghmans RL, Hall SP. The bioethics of human fetal tissue research and therapy. Am J Obstet Gynecol. 1994;170:12-19.
28. Zanjani ED, Lim G, McUlave PB, et al. Adult haematopoietic cells transplanted to sheep fetuses continue to produce adult globins. Nature. 1982;295: 244-246.
29. Crombleholme TM, Harrison MR, Zanjani ED. In utero transplantation of hematopoietic stem cells in sheep. J Pediatr Surg. 1990;25:885-892.
30. Srour EF, Zanjani ED, Brandt JE, et al. Sustained human hematopoiesis in sheep transplanted in utero during early gestation with fractionated adult human bone marrow cells. Blood. 1992;79: 1404-1412.
31. Srour EF, Zanjani ED, Cometta K, et al. Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimerie sheep. Blood. 1993;82:3333-3342.
32. +/lineage-/38-cells contain hematopoeitic stem cells. Blood. 1993;82(suppl 1): 180A. Abstract 707.
33. + human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. Blood. 1996;87:4136-4142.
34. Lansdorp P, Dragowska W, Mayani H. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med. 1993;178:787-791.
35. Zanjani ED, Flake AW, Rice H, Hendrick M, Tavassoli M. An in-vivo comparison of potential human donor hematopoietic stem cell (HSC) sources for bone marrow transplantation using the human/ sheep xenograft model. Blood. 1993;82(suppl 1):655A. Abstract.
36. Flake AW, Zanjani ED. Cellular therapy. In: Reece EA, ed. Fetal diagnosis and therapy. Obstet Gynecol Clin North Am. 1997;24:159-178.
37. Stewart FM, Crittenden RB, Lowry PA, Pearson-White S, Quesenberry PJ. Long-term engraftment of normal and post-5-fluorouracil murine marrowinto normal nonmyeloablated mice. Blood. 1993; 81:2566-2571.
38. Rhoads GG, Jackson LG, Schlesselman SE, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med. 1989;320:609-617.
39. Moise K. Intrauterine transfusion with red cells and platelets. West J Med. 1993;159:318-324.
40. Bowman J. Hemolytic disease (erythroblastosis fetalis). In: Creasy R, Resnick R, eds. Maternal-Fetal Medicine: Principles and Practice. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1994:730-733.
41. McKinnon S, Papadopoulos E, Carabasi M, et al. Adoptive immunotherapy: evaluating escalating doses of donor leukocytes for relapse of CML after BMT. Blood. 1995;86:1261-1268.
42. Manis J, Schwartz RS. Agammaglobulinemia and insights into B-cell differentiation. N Engl J Med. 1996;335:1523-1525. Editorial.
43. Hollenbaugh D, Wu LH, Ochs HD, et al. The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIUM1. J Clin Invest. 1994;94:616-622.
44. Andreani M, Manna M, Lucarelli U, et al. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood. 1996;87:3494-3499.
45. Walters MC, Patience M, Leisenring W, et al. Bone marrow transplantation for sickle cell disease. N Engl J Med. 1996;335:369-376.
46. Moses S. Pathophysiology and dietary treatment of the glycogen storage diseases. J Pediatr Gastroenterol Nutr. 1990;11:155-174.
47. Fletcher JC. Fetal therapy, ethics and public policies. Fetal Diagn Ther. 1992;7:158-168.
48. McCullough LB, Chervenak FA. Ethics in Obstetrics and Gynecology. New York, NY: Oxford University Press; 1994.
49. Chervenak FA, McCullough LB. Does obstetric ethics have any role in the obstetrician's response to the abortion controversy? Am J Obstet Gynecol. 1990;163:1425-1429.